In the current study, some substances were classified as not prohibited even if they were not explicitly described as permitted by sources such as Global DRO or NADAmed, but had been evaluated at least indirectly
Reference lists of studies and reviews identified on the topic were searched to identify additional publications
The gut-brain axis at work @jclinicalinvest jci.org/articles/view/ important finding for refining GLP-1 drugs and reducing the side effects in the future This is relevant to eating disorders
Technology can also enhance remote monitoring of patients on GLP-1 therapy
In the first 4-6 weeks, especially if you're new to structured exercise, err on the side of shorter sessions and lower intensity
Traditionally, AD is tackled with drugs like acetylcholinesterase inhibitors (e.g., donepezil, galantamine, rivastigmine) (35) and the N-Methyl-D-Aspartate (NMDA) receptor allosteric modulator, memantine (68)